9 results on '"Patmore DM"'
Search Results
2. DDX3X Suppresses the Susceptibility of Hindbrain Lineages to Medulloblastoma.
- Author
-
Patmore DM, Jassim A, Nathan E, Gilbertson RJ, Tahan D, Hoffmann N, Tong Y, Smith KS, Kanneganti TD, Suzuki H, Taylor MD, Northcott P, and Gilbertson RJ
- Subjects
- Animals, Brain Neoplasms pathology, Cell Lineage genetics, Gene Expression Regulation, Neoplastic genetics, Genes, Homeobox, Humans, Medulloblastoma pathology, Mice, Mutation genetics, Rhombencephalon metabolism, Rhombencephalon pathology, Wnt Proteins genetics, Brain Neoplasms genetics, DEAD-box RNA Helicases genetics, Hedgehog Proteins genetics, Medulloblastoma genetics
- Abstract
DEAD-Box Helicase 3 X-Linked (DDX3X) is frequently mutated in the Wingless (WNT) and Sonic hedghog (SHH) subtypes of medulloblastoma-the commonest malignant childhood brain tumor, but whether DDX3X functions as a medulloblastoma oncogene or tumor suppressor gene is not known. Here, we show that Ddx3x regulates hindbrain patterning and development by controlling Hox gene expression and cell stress signaling. In mice predisposed to Wnt- or Shh medulloblastoma, Ddx3x sensed oncogenic stress and suppressed tumor formation. WNT and SHH medulloblastomas normally arise only in the lower and upper rhombic lips, respectively. Deletion of Ddx3x removed this lineage restriction, enabling both medulloblastoma subtypes to arise in either germinal zone. Thus, DDX3X is a medulloblastoma tumor suppressor that regulates hindbrain development and restricts the competence of cell lineages to form medulloblastoma subtypes., Competing Interests: Declaration of Interests The authors declare no competing interests., (Copyright © 2020 Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
3. DDX3X acts as a live-or-die checkpoint in stressed cells by regulating NLRP3 inflammasome.
- Author
-
Samir P, Kesavardhana S, Patmore DM, Gingras S, Malireddi RKS, Karki R, Guy CS, Briard B, Place DE, Bhattacharya A, Sharma BR, Nourse A, King SV, Pitre A, Burton AR, Pelletier S, Gilbertson RJ, and Kanneganti TD
- Subjects
- Animals, Cell Line, Cell Survival genetics, DEAD-box RNA Helicases genetics, Gene Expression Profiling, Gene Expression Regulation, Developmental genetics, HEK293 Cells, Humans, Inflammasomes immunology, Macrophages immunology, Mice, NLR Family, Pyrin Domain-Containing 3 Protein genetics, Cell Death genetics, DEAD-box RNA Helicases metabolism, Inflammasomes genetics, Macrophages cytology, NLR Family, Pyrin Domain-Containing 3 Protein metabolism, Stress, Physiological genetics
- Abstract
The cellular stress response has a vital role in regulating homeostasis by modulating cell survival and death. Stress granules are cytoplasmic compartments that enable cells to survive various stressors. Defects in the assembly and disassembly of stress granules are linked to neurodegenerative diseases, aberrant antiviral responses and cancer
1-5 . Inflammasomes are multi-protein heteromeric complexes that sense molecular patterns that are associated with damage or intracellular pathogens, and assemble into cytosolic compartments known as ASC specks to facilitate the activation of caspase-1. Activation of inflammasomes induces the secretion of interleukin (IL)-1β and IL-18 and drives cell fate towards pyroptosis-a form of programmed inflammatory cell death that has major roles in health and disease6-12 . Although both stress granules and inflammasomes can be triggered by the sensing of cellular stress, they drive contrasting cell-fate decisions. The crosstalk between stress granules and inflammasomes and how this informs cell fate has not been well-studied. Here we show that the induction of stress granules specifically inhibits NLRP3 inflammasome activation, ASC speck formation and pyroptosis. The stress granule protein DDX3X interacts with NLRP3 to drive inflammasome activation. Assembly of stress granules leads to the sequestration of DDX3X, and thereby the inhibition of NLRP3 inflammasome activation. Stress granules and the NLRP3 inflammasome compete for DDX3X molecules to coordinate the activation of innate responses and subsequent cell-fate decisions under stress conditions. Induction of stress granules or loss of DDX3X in the myeloid compartment leads to a decrease in the production of inflammasome-dependent cytokines in vivo. Our findings suggest that macrophages use the availability of DDX3X to interpret stress signals and choose between pro-survival stress granules and pyroptotic ASC specks. Together, our data demonstrate the role of DDX3X in driving NLRP3 inflammasome and stress granule assembly, and suggest a rheostat-like mechanistic paradigm for regulating live-or-die cell-fate decisions under stress conditions.- Published
- 2019
- Full Text
- View/download PDF
4. Cancer-associated DDX3X mutations drive stress granule assembly and impair global translation.
- Author
-
Valentin-Vega YA, Wang YD, Parker M, Patmore DM, Kanagaraj A, Moore J, Rusch M, Finkelstein D, Ellison DW, Gilbertson RJ, Zhang J, Kim HJ, and Taylor JP
- Subjects
- Carcinogenesis, HEK293 Cells, HeLa Cells, Humans, Medulloblastoma metabolism, Protein Biosynthesis, Ribosomes metabolism, Single-Cell Analysis, Cerebellar Neoplasms genetics, Cytoplasmic Granules metabolism, DEAD-box RNA Helicases genetics, Medulloblastoma genetics, Mutation genetics
- Abstract
DDX3X is a DEAD-box RNA helicase that has been implicated in multiple aspects of RNA metabolism including translation initiation and the assembly of stress granules (SGs). Recent genomic studies have reported recurrent DDX3X mutations in numerous tumors including medulloblastoma (MB), but the physiological impact of these mutations is poorly understood. Here we show that a consistent feature of MB-associated mutations is SG hyper-assembly and concomitant translation impairment. We used CLIP-seq to obtain a comprehensive assessment of DDX3X binding targets and ribosome profiling for high-resolution assessment of global translation. Surprisingly, mutant DDX3X expression caused broad inhibition of translation that impacted DDX3X targeted and non-targeted mRNAs alike. Assessment of translation efficiency with single-cell resolution revealed that SG hyper-assembly correlated precisely with impaired global translation. SG hyper-assembly and translation impairment driven by mutant DDX3X were rescued by a genetic approach that limited SG assembly and by deletion of the N-terminal low complexity domain within DDX3X. Thus, in addition to a primary defect at the level of translation initiation caused by DDX3X mutation, SG assembly itself contributes to global translation inhibition. This work provides mechanistic insights into the consequences of cancer-related DDX3X mutations, suggesting that globally reduced translation may provide a context-dependent survival advantage that must be considered as a possible contributor to tumorigenesis.
- Published
- 2016
- Full Text
- View/download PDF
5. Medulloblastoma Genotype Dictates Blood Brain Barrier Phenotype.
- Author
-
Phoenix TN, Patmore DM, Boop S, Boulos N, Jacus MO, Patel YT, Roussel MF, Finkelstein D, Goumnerova L, Perreault S, Wadhwa E, Cho YJ, Stewart CF, and Gilbertson RJ
- Subjects
- Animals, Antineoplastic Agents pharmacokinetics, Carrier Proteins physiology, Cerebellar Neoplasms blood supply, Cerebellar Neoplasms classification, Cerebellar Neoplasms drug therapy, Cerebellar Neoplasms metabolism, Culture Media, Conditioned pharmacology, Disease Models, Animal, Drug Resistance, Neoplasm physiology, Endothelium, Vascular metabolism, Endothelium, Vascular ultrastructure, Genetic Association Studies, Genetic Vectors therapeutic use, Genotype, Glucose Transporter Type 1 physiology, Humans, Medulloblastoma blood supply, Medulloblastoma classification, Medulloblastoma drug therapy, Medulloblastoma metabolism, Membrane Proteins physiology, Mice, Mice, Transgenic, Neoplasm Proteins physiology, Paracrine Communication drug effects, Pericytes pathology, Recombinant Fusion Proteins metabolism, Tight Junctions ultrastructure, Transduction, Genetic, Vincristine pharmacokinetics, Vincristine therapeutic use, Wnt Proteins genetics, Wnt Proteins physiology, Wnt Signaling Pathway drug effects, Blood-Brain Barrier, Cerebellar Neoplasms genetics, Medulloblastoma genetics
- Abstract
The childhood brain tumor, medulloblastoma, includes four subtypes with very different prognoses. Here, we show that paracrine signals driven by mutant β-catenin in WNT-medulloblastoma, an essentially curable form of the disease, induce an aberrant fenestrated vasculature that permits the accumulation of high levels of intra-tumoral chemotherapy and a robust therapeutic response. In contrast, SHH-medulloblastoma, a less curable disease subtype, contains an intact blood brain barrier, rendering this tumor impermeable and resistant to chemotherapy. The medulloblastoma-endothelial cell paracrine axis can be manipulated in vivo, altering chemotherapy permeability and clinical response. Thus, medulloblastoma genotype dictates tumor vessel phenotype, explaining in part the disparate prognoses among medulloblastoma subtypes and suggesting an approach to enhance the chemoresponsiveness of other brain tumors., (Copyright © 2016 Elsevier Inc. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
6. Insertional Mutagenesis Identifies a STAT3/Arid1b/β-catenin Pathway Driving Neurofibroma Initiation.
- Author
-
Wu J, Keng VW, Patmore DM, Kendall JJ, Patel AV, Jousma E, Jessen WJ, Choi K, Tschida BR, Silverstein KA, Fan D, Schwartz EB, Fuchs JR, Zou Y, Kim MO, Dombi E, Levy DE, Huang G, Cancelas JA, Stemmer-Rachamimov AO, Spinner RJ, Largaespada DA, and Ratner N
- Subjects
- Animals, Carcinogenesis metabolism, Carcinogenesis pathology, DNA Helicases genetics, DNA Helicases metabolism, DNA-Binding Proteins antagonists & inhibitors, DNA-Binding Proteins metabolism, Disease Models, Animal, Female, Glycogen Synthase Kinase 3 beta antagonists & inhibitors, Glycogen Synthase Kinase 3 beta genetics, Glycogen Synthase Kinase 3 beta metabolism, Histones genetics, Histones metabolism, Humans, Mice, Mice, Nude, Mutagenesis, Insertional, N-Terminal Acetyltransferase A antagonists & inhibitors, N-Terminal Acetyltransferase A metabolism, Neoplasm Transplantation, Neural Stem Cells metabolism, Neural Stem Cells pathology, Neurofibromatosis 1 metabolism, Neurofibromatosis 1 pathology, Neurofibromin 1 genetics, Neurofibromin 1 metabolism, Nuclear Proteins genetics, Nuclear Proteins metabolism, Peripheral Nervous System Neoplasms metabolism, Peripheral Nervous System Neoplasms pathology, Phosphorylation, RNA, Small Interfering genetics, RNA, Small Interfering metabolism, STAT3 Transcription Factor antagonists & inhibitors, STAT3 Transcription Factor metabolism, Schwann Cells metabolism, Schwann Cells pathology, Signal Transduction, Transcription Factors genetics, Transcription Factors metabolism, beta Catenin metabolism, Carcinogenesis genetics, DNA-Binding Proteins genetics, Gene Expression Regulation, Neoplastic, N-Terminal Acetyltransferase A genetics, Neurofibromatosis 1 genetics, Peripheral Nervous System Neoplasms genetics, STAT3 Transcription Factor genetics, beta Catenin genetics
- Abstract
To identify genes and signaling pathways that initiate Neurofibromatosis type 1 (NF1) neurofibromas, we used unbiased insertional mutagenesis screening, mouse models, and molecular analyses. We mapped an Nf1-Stat3-Arid1b/β-catenin pathway that becomes active in the context of Nf1 loss. Genetic deletion of Stat3 in Schwann cell progenitors (SCPs) and Schwann cells (SCs) prevents neurofibroma formation, decreasing SCP self-renewal and β-catenin activity. β-catenin expression rescues effects of Stat3 loss in SCPs. Importantly, P-STAT3 and β-catenin expression correlate in human neurofibromas. Mechanistically, P-Stat3 represses Gsk3β and the SWI/SNF gene Arid1b to increase β-catenin. Knockdown of Arid1b or Gsk3β in Stat3(fl/fl);Nf1(fl/fl);DhhCre SCPs rescues neurofibroma formation after in vivo transplantation. Stat3 represses Arid1b through histone modification in a Brg1-dependent manner, indicating that epigenetic modification plays a role in early tumorigenesis. Our data map a neural tumorigenesis pathway and support testing JAK/STAT and Wnt/β-catenin pathway inhibitors in neurofibroma therapeutic trials., (Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
7. EGFR-STAT3 signaling promotes formation of malignant peripheral nerve sheath tumors.
- Author
-
Wu J, Patmore DM, Jousma E, Eaves DW, Breving K, Patel AV, Schwartz EB, Fuchs JR, Cripe TP, Stemmer-Rachamimov AO, and Ratner N
- Subjects
- Animals, Cells, Cultured, Curcumin analogs & derivatives, Curcumin pharmacology, Genes, Neurofibromatosis 1, Humans, Janus Kinase 2 physiology, Mice, Mice, Inbred C57BL, STAT3 Transcription Factor antagonists & inhibitors, Sarcoma etiology, ErbB Receptors physiology, Nerve Sheath Neoplasms etiology, STAT3 Transcription Factor physiology, Signal Transduction physiology
- Abstract
Malignant peripheral nerve sheath tumors (MPNSTs) develop sporadically or in the context of neurofibromatosis type 1. Epidermal growth factor receptor (EGFR) overexpression has been implicated in MPNST formation, but its precise role and relevant signaling pathways remain unknown. We found that EGFR overexpression promotes mouse neurofibroma transformation to aggressive MPNST (GEM-PNST). Immunohistochemistry demonstrated phosphorylated STAT3 (Tyr705) in both human MPNST and mouse GEM-PNST. A specific JAK2/STAT3 inhibitor FLLL32 delayed MPNST formation in an MPNST xenograft nude mouse model. STAT3 knockdown by shRNA prevented MPNST formation in vivo. Finally, reducing EGFR activity strongly reduced pSTAT3 in vivo. Thus, an EGFR-STAT3 pathway is necessary for MPNST transformation and establishment of MPNST xenografts growth but not for tumor maintenance. Efficacy of the FLLL32 pharmacological inhibitor in delaying MPNST growth suggests that combination therapies targeting JAK/STAT3 might be useful therapeutics.
- Published
- 2014
- Full Text
- View/download PDF
8. In vivo regulation of TGF-β by R-Ras2 revealed through loss of the RasGAP protein NF1.
- Author
-
Patmore DM, Welch S, Fulkerson PC, Wu J, Choi K, Eaves D, Kordich JJ, Collins MH, Cripe TP, and Ratner N
- Subjects
- Animals, Blotting, Western, Humans, Mice, Neurofibromin 1 genetics, Transforming Growth Factor beta physiology, ras Proteins physiology
- Abstract
Ras superfamily proteins participate in TGF-β-mediated developmental pathways that promote either tumor suppression or progression. However, the specific Ras proteins, which integrate in vivo with TGF-β signaling pathways, are unknown. As a general approach to this question, we activated all Ras proteins in vivo by genetic deletion of the RasGAP protein Nf1 and examined mice doubly deficient in a Ras protein to determine its requirement in formation of TGF-β-dependent neurofibromas that arise in Nf1-deficient mice. Animals lacking Nf1 and the Ras-related protein R-Ras2/TC21 displayed a delay in formation of neurofibromas but an acceleration in formation of brain tumors and sarcomas. Loss of R-Ras2 was associated with elevated expression of TGF-β in Nf1-deficient Schwann cell precursors, blockade of a Nf1/TGFβRII/AKT-dependent autocrine survival loop in tumor precursor cells, and decreased precursor cell numbers. Furthermore, the increase in size of sarcomas from xenografts doubly deficient in these genes was also found to be TGF-β-dependent, in this case resulting from cell nonautonomous effects on endothelial cells and myofibroblasts. Extending these findings in clinical specimens, we documented an increase in TGF-β ligands and an absence of TGF-β receptor II in malignant peripheral nerve sheath tumors, which correspond to tumors in the Nf1-deficient mouse model. Together, our findings reveal R-Ras2 as a critical regulator of TGF-β signaling in vivo.
- Published
- 2012
- Full Text
- View/download PDF
9. Inhibition of Eyes Absent Homolog 4 expression induces malignant peripheral nerve sheath tumor necrosis.
- Author
-
Miller SJ, Lan ZD, Hardiman A, Wu J, Kordich JJ, Patmore DM, Hegde RS, Cripe TP, Cancelas JA, Collins MH, and Ratner N
- Subjects
- Animals, Blotting, Western, Cell Line, Tumor, Cells, Cultured, Cluster Analysis, Eye Proteins genetics, Eye Proteins metabolism, Female, Gene Expression Profiling, Gene Expression Regulation, Neoplastic, Homeodomain Proteins genetics, Homeodomain Proteins metabolism, Humans, Intracellular Signaling Peptides and Proteins genetics, Intracellular Signaling Peptides and Proteins metabolism, Mice, Mice, Nude, Necrosis, Neoplasms, Experimental metabolism, Neoplasms, Experimental pathology, Nerve Sheath Neoplasms metabolism, Nerve Sheath Neoplasms pathology, Nuclear Proteins genetics, Nuclear Proteins metabolism, Oligonucleotide Array Sequence Analysis methods, PAX6 Transcription Factor, Paired Box Transcription Factors genetics, Paired Box Transcription Factors metabolism, Protein Tyrosine Phosphatases genetics, Protein Tyrosine Phosphatases metabolism, Repressor Proteins genetics, Repressor Proteins metabolism, Reverse Transcriptase Polymerase Chain Reaction, Trans-Activators metabolism, Transcription Factors genetics, Transcription Factors metabolism, Transplantation, Heterologous, Neoplasms, Experimental genetics, Nerve Sheath Neoplasms genetics, RNA Interference, Trans-Activators genetics
- Abstract
Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive sarcomas without effective therapeutics. Bioinformatics was used to identify potential therapeutic targets. Paired Box (PAX), Eyes Absent (EYA), Dachsund (DACH) and Sine Oculis (SIX) genes, which form a regulatory interactive network in Drosophila, were found to be dysregulated in human MPNST cell lines and solid tumors. We identified a decrease in DACH1 expression, and increases in the expressions of PAX6, EYA1, EYA2, EYA4, and SIX1-4 genes. Consistent with the observation that half of MPNSTs develop in neurofibromatosis type 1 (NF1) patients, subsequent to NF1 mutation, we found that exogenous expression of the NF1-GTPase activating protein-related domain normalized DACH1 expression. EYA4 mRNA was elevated more than 100-fold as estimated by quantitative real-time PCR in most MPNST cell lines. In vitro, suppression of EYA4 expression using short hairpin RNA reduced cell adhesion and migration and caused cellular necrosis without affecting cell proliferation or apoptotic cell death. MPNST cells expressing shEYA4 either failed to form tumors in nude mice or formed very small tumors, with extensive necrosis but similar levels of proliferation and apoptosis as control cells. Our findings identify a role of EYA4 and possibly interacting SIX and DACH proteins in MPNSTs and suggest the EYA4 pathway as a rational therapeutic target.
- Published
- 2010
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.